Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron S Kelly

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Endocrine Development|December 20, 2015
Glucagon-Like Peptide-1 Receptor Agonist Treatment for Pediatric ObesityAaron S Kelly
Nature Reviews. Endocrinology|June 19, 2023
Current and future pharmacotherapies for obesity in children and adolescentsAaron S Kelly
Mayo Clinic Proceedings|January 10, 2017
Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and TreatmentSeema Kumar, Aaron S Kelly
Journal of Diabetes and Its Complications|September 11, 2007
The cardiovascular effects of the thiazolidinediones: a review of the clinical dataAaron S Kelly, Alan J Bank
Frontiers in Pediatrics|December 14, 2018
The Potential Role of Combination Pharmacotherapy to Improve Outcomes of Pediatric Obesity: A Case Report and DiscussionClaudia K Fox, Aaron S Kelly
Current Diabetes Reports|June 25, 2017
Pharmacotherapy in the Management of Pediatric ObesityAaron S Kelly, Claudia K Fox
Journal of Cardiac Failure|March 8, 2006
Tissue Doppler imaging and left ventricular dyssynchrony in heart failureAlan J Bank, Aaron S Kelly
Frontiers in Endocrinology|November 17, 2022
Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adultsMegan O Bensignor, Aaron S Kelly, Silva Arslanian
Obesity (Silver Spring, Md.)|May 8, 2018
Treatment Options for Severe Obesity in the Pediatric Population: Current Limitations and Future OpportunitiesJustin R Ryder, Claudia K Fox, Aaron S Kelly
Nutrients|January 28, 2026
Obesity Phenotyping in Children and Adolescents: Next Steps Towards Precision Medicine in Pediatric ObesityLeslie Saba, Andres J Acosta, Aaron S Kelly, et al.
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Endocrine Development|December 20, 2015
Glucagon-Like Peptide-1 Receptor Agonist Treatment for Pediatric ObesityAaron S Kelly
Nature Reviews. Endocrinology|June 19, 2023
Current and future pharmacotherapies for obesity in children and adolescentsAaron S Kelly
Mayo Clinic Proceedings|January 10, 2017
Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and TreatmentSeema Kumar, Aaron S Kelly
Journal of Diabetes and Its Complications|September 11, 2007
The cardiovascular effects of the thiazolidinediones: a review of the clinical dataAaron S Kelly, Alan J Bank
Frontiers in Pediatrics|December 14, 2018
The Potential Role of Combination Pharmacotherapy to Improve Outcomes of Pediatric Obesity: A Case Report and DiscussionClaudia K Fox, Aaron S Kelly
Current Diabetes Reports|June 25, 2017
Pharmacotherapy in the Management of Pediatric ObesityAaron S Kelly, Claudia K Fox
Journal of Cardiac Failure|March 8, 2006
Tissue Doppler imaging and left ventricular dyssynchrony in heart failureAlan J Bank, Aaron S Kelly
Frontiers in Endocrinology|November 17, 2022
Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adultsMegan O Bensignor, Aaron S Kelly, Silva Arslanian
Obesity (Silver Spring, Md.)|May 8, 2018
Treatment Options for Severe Obesity in the Pediatric Population: Current Limitations and Future OpportunitiesJustin R Ryder, Claudia K Fox, Aaron S Kelly
Nutrients|January 28, 2026
Obesity Phenotyping in Children and Adolescents: Next Steps Towards Precision Medicine in Pediatric ObesityLeslie Saba, Andres J Acosta, Aaron S Kelly, et al.
Pageof 17